LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026)
LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 19.06% |
| 10 | LivaNova | 4.39 Bn | 3.85 Bn | 243.75 Mn | -59.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.32% |
| Dec 31, 2025 | -39.56% |
| Sep 30, 2025 | -30.62% |
| Jun 30, 2025 | -31.12% |
| Mar 31, 2025 | 13.33% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | 6.65% |
| Jun 30, 2024 | 3.25% |
| Mar 31, 2024 | 10.71% |
| Dec 31, 2023 | 11.56% |
| Sep 30, 2023 | 5.10% |
| Jun 30, 2023 | 29.92% |
| Mar 31, 2023 | 22.01% |
| Dec 31, 2022 | 16.09% |
| Sep 30, 2022 | 20.88% |
| Jun 30, 2022 | -29.71% |
| Mar 31, 2022 | -29.76% |
| Dec 31, 2021 | -29.75% |
| Sep 30, 2021 | -29.01% |
| Jun 30, 2021 | -2.00% |